Effects of Alpha-Lipoic Acid Supplementation on Cardiovascular Disease Risk Factors in β-Thalassemia Major Patients: A Clinical Trial Crossover Study

AIM: Thalassemia is one of the most common genetic diseases, and cardiovascular disease (CVD) has been considered as the leading cause of mortality in more than 50% of β-thalassemia patients. The aim of this study was to determine the effects of alpha-lipoic acid (ALA) on CVD risk factors in β-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamshidi, Khadijeh, Abdollahzad, Hadi, Nachvak, Mostafa, Rezaei, Mansour, Golpayegani, Mohammad Reza, Sharifi Zahabi, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225175/
https://www.ncbi.nlm.nih.gov/pubmed/32494211
http://dx.doi.org/10.2147/JBM.S252105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225175/
https://www.ncbi.nlm.nih.gov/pubmed/32494211
http://dx.doi.org/10.2147/JBM.S252105

Ejemplares similares